E
EndoGastric Solutions
Incisionless transoral procedures to treat gastrointestinal diseases
About EndoGastric Solutions
EndoGastric Solutions is a pioneering company in the medical field, focusing on the endoluminal treatment of digestive diseases, particularly Gastroesophageal Reflux Disease (GERD). The company operates in the healthcare market, providing advanced medical procedures and devices to physicians and healthcare providers. Their core product, the Transoral Incisionless Fundoplication (TIF) procedure, offers a minimally invasive solution for GERD sufferers, aiming to improve patient outcomes and quality of life. EndoGastric Solutions generates revenue through the sale of their proprietary medical devices, training programs for physicians, and ongoing support services. The company serves a wide range of clients, including hospitals, clinics, and individual healthcare practitioners. By leveraging innovative technology and clinical research, EndoGastric Solutions positions itself as a leader in its niche market.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2002
- Headquarters
- Redmond, United States
- Employees
- 16
- Open positions
- None listed
- Dealroom signal
- 66.7/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Surgery, Gastroenterology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Dec 2022 | $18M | $135M | Undisclosed | ↗ |
| LATE VCOther financing | Dec 2020 | $27M | $108M | Undisclosed | — |
Growth signals
Latest recorded traffic for EndoGastric Solutions is 720 monthly website visits, down 92.8% over the last three months. EndoGastric Solutions's team declined 15.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later11 investors entered at this stage
- DVDeNovo Ventures
- AVAdvanced Technology Ventures
Canaan- CPChicago Growth Partners
- FPFoundation Medical Partners
Radius Ventures- OIOakwood Medical Investors
- CLCRG LP
SightLine Partners
Evidity Health Capital
Accelmed
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about EndoGastric Solutions on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See EndoGastric Solutions’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.




